Scancell - Media

Press Release Index

24 September 2008

Scancell admission to trading on PLUS
Full details

30 April 2008

Reports and accounts April 2008
Full details

04 December 2006

Scancell sells antibody pipeline to Peptech
Full details

28 July 2005

GTC Biotherapeutics and Scancell Collaborate on SC101 Antibody
Full details

15 June 2005

Scancell Raises £1.0 Million In Rights Issue
Full details

11 January 2005

Scancell Signs New Agreement with Biovation to DeImmunise SC101
Full details

25 May 2004

Scancell Secures Exclusive Worldwide Licence Agreement with Cancer Research Technology for two Novel Cancer Vaccines
Full details

27 April 2004

Scancell Raises £1.3 Million ($2.34M; €2M) in New Funding Round and Announces Move to BioCity Nottingham
Full details

21 April 2004

Scancell Appoints Dr Michael Capaldi as CEO
Full details

12 December 2003

Scancell, Onyvax and CRT Announce Agreement to Facilitate the Development of "ImmunoBody" Cancer Vaccine Technology
Full details

5 August 2003

Scancell and Celltech Announce that they will Collaborate on the Development of Novel Monoclonal Antibody Therapeutics to Lewis^y/b, a Promising New Cancer Target
Full details

4 February 2002

Scancell and Isu Chemical Announce Collaboration and Licensing Agreement for Scancell's Antibody Cancer Drug SC100 in the Far East
Full details

9 October 2001

Genmab and Scancell Announce Cancer Antibody Product Collaboration — First Disease Target Identified
Full details

News